STAT+: Eli Lilly’s obesity pill helped lower weight, blood sugar in key Phase 3 trial
Eli Lilly’s investigational obesity pill helped lower weight and blood sugar in patients with obesity and type 2 diabetes.
Previous Post
Nomi Health Report Reveals the “MSK Paradox”: Why Office Workers Have Higher Injury Rates
Next Post
‘Wholly inappropriate’ for GPs to give 24-hour clinical advice to all patients, says BMA
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago